Breast conserving surgery removes a cancerous tumor and a small rim of surrounding healthy tissue while keeping the rest of the breast intact. You may also hear it called a lumpectomy, partial mastectomy, or segmental mastectomy. It is the standard surgical treatment for early-stage breast cancer (stage I and small stage II tumors) and is almost always followed by radiation therapy to reduce the chance of the cancer returning.
How It Differs From Mastectomy
The key distinction is straightforward: mastectomy removes the entire breast, while breast conserving surgery removes only the tumor and a margin of normal tissue around it. When paired with radiation, breast conserving surgery produces survival outcomes that match or slightly exceed those of mastectomy alone for early-stage disease. In a large study of women with stage I to IIA breast cancer, the 10-year overall survival rate was 93% for women who had breast conserving therapy compared with 89% for those who had mastectomy without radiation. Disease-free survival followed a similar pattern, at 96% versus 90% over ten years.
These numbers may seem counterintuitive. Removing less tissue sounds like it should be riskier. But the addition of radiation to the conserved breast effectively eliminates microscopic cancer cells that surgery alone might miss, which is why the two approaches perform so similarly over the long term.
Who Is a Good Candidate
Most women with small to moderately sized tumors (classified as T1 or small T2, generally up to about 5 cm) are candidates, provided the surgeon can remove the tumor with clear margins and leave a breast that looks reasonably normal afterward. There is no strict size cutoff. What matters is the ratio of tumor size to breast size and whether the cancer can be fully excised.
Some situations rule out breast conserving surgery entirely:
- Cancer in multiple areas of the breast (multicentric disease), where tumors appear in separate quadrants
- Widespread suspicious calcifications on a mammogram, suggesting disease extends beyond what imaging can clearly define
- Pregnancy in the first or second trimester, because radiation cannot safely be given during that time
- Prior radiation to the chest wall, since the breast cannot be safely irradiated a second time
- Known BRCA1 or BRCA2 gene mutations, which carry a high lifetime risk of new breast cancers and often make mastectomy more practical
Research suggests that only about 20% of women who undergo breast surgery actually have absolute contraindications to breast conservation, meaning the majority of early-stage patients have a real choice between the two approaches.
What Happens During Surgery
The surgeon makes an incision over or near the tumor, removes it along with a surrounding shell of healthy tissue, and sends the specimen to a pathologist. The goal is to achieve what’s called a “negative margin,” meaning no cancer cells are found at the edge of the removed tissue. For invasive breast cancer, the standard is “no ink on tumor,” a guideline established by a joint consensus of major oncology organizations in 2014. For ductal carcinoma in situ (DCIS), a non-invasive form, the recommended margin is at least 2 millimeters of clear tissue.
If the pathologist finds cancer cells at or very close to the cut edge, a second procedure to remove additional tissue may be needed. This is one reason surgeons aim to take enough tissue the first time while still preserving the breast’s shape.
Checking the Lymph Nodes
During the same operation, the surgeon typically performs a sentinel lymph node biopsy. This involves removing the first one to three lymph nodes that drain the breast and checking them for cancer cells. If the sentinel nodes are clear, no further lymph node removal is needed. Even when cancer is found in one or two sentinel nodes, research has shown that women with early-stage breast cancer who are having breast conserving surgery with radiation can safely skip a more extensive lymph node removal without affecting long-term survival. A full axillary lymph node dissection is still considered for women with three or more positive nodes, large tumors over 5 cm, or palpable lumps in the armpit.
Why Radiation Follows Surgery
Radiation after breast conserving surgery is not optional for most patients. A major meta-analysis that pooled data from over 10,800 women across 17 trials found that radiation cut the 10-year recurrence risk roughly in half. For women whose cancer had not spread to the lymph nodes, recurrence dropped from 31% to about 16%. For those with node-positive disease, recurrence fell from 64% to 43%.
Without radiation, about three-quarters of recurrences showed up as local disease in or near the breast. With radiation, the pattern shifted: local recurrences dropped dramatically (from 25% to 8%), while distant recurrences stayed about the same. In other words, radiation’s main job is mopping up any remaining cancer cells in the breast itself. A typical course runs five to six weeks of daily treatments, though shorter schedules of three to four weeks are now common for many patients.
Oncoplastic Techniques for Better Cosmetic Results
When a tumor is large relative to the breast, or when it sits in a cosmetically sensitive area like near the nipple, surgeons increasingly use oncoplastic techniques. These combine cancer removal with plastic surgery principles to reshape the remaining breast tissue during the same operation.
The two main approaches are volume displacement and volume replacement. Volume displacement rearranges the remaining breast tissue, using glandular flaps to fill the gap left by the tumor. For women with larger breasts, this may look like a breast reduction performed on both sides, which is actually the most widely used oncoplastic technique. Volume replacement brings in tissue from a nearby area, such as the back or side, to rebuild the breast’s contour. Specific incision patterns like the “bat-wing” or “round block” allow the surgeon to remove tumors in tricky locations while keeping scarring minimal and the breast shape natural.
These techniques have expanded breast conserving surgery to women who previously would have needed a mastectomy because of tumor size or location.
Recovery Timeline
Breast conserving surgery is typically an outpatient procedure, meaning you go home the same day. If a drain is placed to prevent fluid buildup, it usually comes out one to three weeks after surgery once the output slows down. Fluid collection (seroma) is the most common complication of breast and axillary surgery, and while it sometimes requires draining with a needle in the office, it generally resolves on its own.
For the first six weeks, you should avoid lifting anything heavier than five to ten pounds and keep your arms below shoulder height. Strenuous exercise is off the table during this period. Most people return to work around six weeks after surgery, sometimes earlier with light duties. Radiation, if it follows on schedule, typically begins a few weeks after the surgical site has healed, so the full treatment timeline from surgery through the last radiation session often spans about three to four months.
The breast may look and feel different afterward. Swelling, firmness, and changes in sensitivity are common in the months following surgery and radiation. The final cosmetic result often continues to improve over the first year as swelling subsides and tissues settle.